Pharmacodynamic half-life and effect-time course in renal impairment.
Keller
F
F
Division of Nephrology, University Hospital Ulm, Germany.
Czock
D
D
D006207:Half-Life; D006801:Humans; D010830:Physostigmine / Q000493:pharmacokinetics*; D051437:Renal Insufficiency / Q000378:metabolism*
D010830:Physostigmine